Compare FSTR & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FSTR | LAB |
|---|---|---|
| Founded | 1902 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 308.9M | 354.1M |
| IPO Year | 1995 | 2008 |
| Metric | FSTR | LAB |
|---|---|---|
| Price | $29.79 | $0.97 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 1 |
| Target Price | ★ $32.00 | $1.35 |
| AVG Volume (30 Days) | 67.4K | ★ 2.4M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 61.54 |
| EPS | ★ 0.69 | N/A |
| Revenue | ★ $540,009,000.00 | $101,937,000.00 |
| Revenue This Year | $5.12 | N/A |
| Revenue Next Year | $2.78 | $2.63 |
| P/E Ratio | $43.48 | ★ N/A |
| Revenue Growth | ★ 1.74 | N/A |
| 52 Week Low | $17.16 | $0.87 |
| 52 Week High | $32.63 | $1.72 |
| Indicator | FSTR | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 59.80 | 52.37 |
| Support Level | $27.00 | $0.92 |
| Resistance Level | $30.01 | $1.01 |
| Average True Range (ATR) | 0.84 | 0.05 |
| MACD | 0.24 | 0.01 |
| Stochastic Oscillator | 69.60 | 88.90 |
L.B. Foster Co is a technology solutions provider of products and services for the rail and infrastructure markets. The company has two reporting segments: Rail, Technologies, and Services (Rail); and Infrastructure Solutions (Infrastructure). Maximum revenue is generated from the Rail segment, which is comprised of several manufacturing and distribution businesses that provide products and services for freight and passenger railroads and industrial companies throughout the world. The Infrastructure segment offers engineered precast concrete solutions, as well as fabricated bridge, protective pipe coating, and pipe threading offerings across North America. Geographically, the company generates maximum revenue from the United States, followed by Canada, the UK, and other markets.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.